ClinicalTrials.Veeva

Menu

Immune Status in Solid Organ Transplantation

Dartmouth Health logo

Dartmouth Health

Status

Completed

Conditions

Organ Transplants

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01070901
PROG-9F09

Details and patient eligibility

About

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Enrollment

20 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Impending kidney transplant
  • Age >18
  • Able to provide informed consent and comply with the study procedures

Exclusion criteria

  • Age<18
  • Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial

Trial design

20 participants in 1 patient group

Organ transplant recipients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems